9.52 USD
↘ 0.34 (3.45%)LIVE (AS OF 02:00 PM EST)
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is currently trading at $9.52. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, CTNM appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 13, 2026.